Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review.
Armenian P, Vo KT, Barr-Walker J, Lynch KL.
Neuropharmacology. 2018 May 15;134(Pt A):121-132. doi: 10.1016/j.neuropharm.2017.10.016. Epub 2017 Oct 14.
Are opioid receptor antagonists adequate for "Opioid" overdose in a changing reality?
Peppin JF, Pergolizzi JV Jr, Dahan A, Raffa RB.
J Clin Pharm Ther. 2021 Aug;46(4):861-866. doi: 10.1111/jcpt.13320. Epub 2021 Apr 28.
Naloxone.
Handal KA, Schauben JL, Salamone FR.
Ann Emerg Med. 1983 Jul;12(7):438-45. doi: 10.1016/s0196-0644(83)80343-6.
Naloxone nasal spray.
[No authors listed]
Drug Ther Bull. 2019 Sep;57(9):137-140. doi: 10.1136/dtb.2019.000035. Epub 2019 Jul 11.
Intranasal Naloxone Administration.
Ortega R, Nozari A, Baker W, Surani S, Edwards M.
N Engl J Med. 2021 Mar 25;384(12):e44. doi: 10.1056/NEJMvcm2020745.
Phenibut overdose.
Sankary S, Canino P, Jackson J.
Am J Emerg Med. 2017 Mar;35(3):516.e1-516.e2. doi: 10.1016/j.ajem.2016.08.067. Epub 2016 Sep 1.
Fentanyl misuse.
Ruzycki S, Yarema M.
CMAJ. 2016 Jun 14;188(9):673. doi: 10.1503/cmaj.151378. Epub 2016 Apr 18.
U-47700: A Clinical Review of the Literature.
Rambaran KA, Fleming SW, An J, Burkhart S, Furmaga J, Kleinschmidt KC, Spiekerman AM, Alzghari SK.
J Emerg Med. 2017 Oct;53(4):509-519. doi: 10.1016/j.jemermed.2017.05.034. Epub 2017 Sep 12.
Naloxone.
Martin WR.
Ann Intern Med. 1976 Dec;85(6):765-8. doi: 10.7326/0003-4819-85-6-765.
Highly-selective -opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model.
Bartlett MJ, So LY, Szabò L, Skinner DP, Parent KL, Heien ML, Vanderah TW, Polt R, Sherman SJ, Falk T.
BMC Res Notes. 2020 Mar 12;13(1):149. doi: 10.1186/s13104-020-04994-7.
